Literature DB >> 23292177

ANCA-associated vasculitis: report from Korea.

Hye Won Kim1, Yeong Wook Song2,3.   

Abstract

We investigated the clinical features of Korean patients with anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) by reviewing the literature. The characteristics of AAV in Korean patients were as follows: (1) granulomatous and limited disease is prevalent in granulomatosis with polyangiitis (Wegener's) (GPA), (2) ANCA positivity is lower in GPA (56.6-68.9%) and eosinophilic granulomatosis with polyangiitis (EGPA) (5.9-8.3%), whereas it is higher in microscopic polyangiitis (MPA) (69-94%), (3) C-ANCA/proteinase 3 (PR3)-ANCA positivity is 71.5-100% in GPA and P-ANCA/myeloperoxidase (MPO)-ANCA positivity reached 94-100% in patients with MPA, (4) renal involvement or progression to end-stage renal disease was lower in Korean patients with GPA and EGPA than in Caucasians with GPA and EGPA (according to data provided in reports). The data provided here may need to be confirmed in large-scale studies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23292177     DOI: 10.1007/s10157-012-0754-8

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  19 in total

1.  Clinical manifestations and treatment of Wegener's granulomatosis.

Authors:  Julia U Holle; Martin Laudien; Wolfgang L Gross
Journal:  Rheum Dis Clin North Am       Date:  2010-08       Impact factor: 2.670

Review 2.  Nomenclature of systemic vasculitides. Proposal of an international consensus conference.

Authors:  J C Jennette; R J Falk; K Andrassy; P A Bacon; J Churg; W L Gross; E C Hagen; G S Hoffman; G G Hunder; C G Kallenberg
Journal:  Arthritis Rheum       Date:  1994-02

Review 3.  Update on clinical, pathophysiological and therapeutic aspects in ANCA-associated vasculitides.

Authors:  Peter Lamprecht; Julia Holle; Wolfgang L Gross
Journal:  Curr Drug Discov Technol       Date:  2009-12

4.  Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies.

Authors:  Richard Watts; Suzanne Lane; Thomas Hanslik; Thomas Hauser; Bernhard Hellmich; Wenche Koldingsnes; Alfred Mahr; Mårten Segelmark; Jan W Cohen-Tervaert; David Scott
Journal:  Ann Rheum Dis       Date:  2006-08-10       Impact factor: 19.103

5.  Churg-Strauss syndrome: the clinical features and long-term follow-up of 17 patients.

Authors:  Mi Jung Oh; Jin Young Lee; Nam Hee Kwon; Dong Chull Choi
Journal:  J Korean Med Sci       Date:  2006-04       Impact factor: 2.153

6.  Neurologic manifestations of Churg-Strauss syndrome.

Authors:  M Sehgal; J W Swanson; R A DeRemee; T V Colby
Journal:  Mayo Clin Proc       Date:  1995-04       Impact factor: 7.616

7.  Churg-Strauss syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists.

Authors:  Karina A Keogh; Ulrich Specks
Journal:  Am J Med       Date:  2003-09       Impact factor: 4.965

Review 8.  Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome.

Authors:  J G Lanham; K B Elkon; C D Pusey; G R Hughes
Journal:  Medicine (Baltimore)       Date:  1984-03       Impact factor: 1.889

9.  Assessment of the item selection and weighting in the Birmingham vasculitis activity score for Wegener's granulomatosis.

Authors:  Alfred D Mahr; Tuhina Neogi; Michael P Lavalley; John C Davis; Gary S Hoffman; W Joseph McCune; Ulrich Specks; Robert F Spiera; E William St Clair; John H Stone; Peter A Merkel
Journal:  Arthritis Rheum       Date:  2008-06-15

10.  Pulmonary involvement in Churg-Strauss syndrome: an analysis of CT, clinical, and pathologic findings.

Authors:  Yoon Kyung Kim; Kyung Soo Lee; Man Pyo Chung; Joungho Han; Semin Chong; Myung Jin Chung; Chin A Yi; Ha Young Kim
Journal:  Eur Radiol       Date:  2007-06-29       Impact factor: 5.315

View more
  1 in total

1.  Granulomatosis with polyangiitis: clinical course and outcome of 60 patients from a single center in South India.

Authors:  Vineeta Shobha; Saba Fathima; Ravi Prakash
Journal:  Clin Exp Med       Date:  2018-02-28       Impact factor: 3.984

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.